Identification of new biomarkers by analyses of exosomes derived from activated endothlial cells
Not Applicable
- Conditions
- chronic obstructive pulmonary disease (COPD):stable phase and acute exacerbation, interstitial pneumonia(IP)
- Registration Number
- JPRN-UMIN000014672
- Lead Sponsor
- Tohoku University
- Brief Summary
Serum activated endothelium-specific exosomes were analysed in COPD patient samples. No association with stage or prognosis was found.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 117
Inclusion Criteria
Not provided
Exclusion Criteria
patients and healthy volunteers who deny participating in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in circulating exosomes derived from activated endothelial cells at a stable or an acute exacerbation phase of COPD patients or IP patients.
- Secondary Outcome Measures
Name Time Method